{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:53:44Z","timestamp":1781636024702,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cooperative Research Project Program of the Institute for Protein Research at Osaka University","award":["ICR-25-42"],"award-info":[{"award-number":["ICR-25-42"]}]},{"name":"Grant-in-Aid for JSPS Fellows","award":["24KF0066"],"award-info":[{"award-number":["24KF0066"]}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H03376"],"award-info":[{"award-number":["21H03376"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Heart failure (HF) remains a major clinical challenge with poor prognosis despite extensive research and established treatments. Extracellular ATP and adenosine (Ado), as damage-associated molecular patterns (DAMPs), contribute to HF pathogenesis through pro-inflammatory effects. However,\n                    <jats:italic>in vivo<\/jats:italic>\n                    evidence of ATP\/Ado dynamics in failing hearts remains elusive. In this study, we investigated the spatiotemporal dynamics of extracellular Ado in a zebrafish HF model using a genetically encoded heart-specific extracellular Ado sensor (GRAB\n                    <jats:sub>Ado<\/jats:sub>\n                    ). Terfenadine-induced HF zebrafish showed increased extracellular cardiac Ado, indirectly reflecting elevated extracellular ATP release. These findings demonstrate a strong correlation between extracellular ATP\/Ado dynamics and HF progression. Furthermore, pharmacological inhibition of vesicular nucleotide transporter (VNUT), a key regulator of ATP vesicle exocytosis, reduced extracellular ATP\/Ado levels and ameliorated cardiac dysfunction in the HF model. Co-treatment with a VNUT inhibitor and purinergic modulators showed additive therapeutic effects. Thus, this study aimed to provide\n                    <jats:italic>in vivo<\/jats:italic>\n                    evidence linking extracellular ATP\/Ado signaling to HF pathophysiology and highlight VNUT as a novel therapeutic target for HF. Given the multifactorial nature of HF and the limited success of current anti-inflammatory strategies, targeting purinergic signaling through VNUT inhibition offers a promising approach for managing inflammatory mechanisms in HF.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-30303-y","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:05:59Z","timestamp":1770815159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In vivo visualization of cardiac extracellular adenosine dynamics and its pharmacological modulation in zebrafish heart failure models"],"prefix":"10.1038","volume":"16","author":[{"given":"Phurpa","family":"Phurpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdeline E. Carrasco","family":"Apolinario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Teranishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenshiro","family":"Shikano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatoshi","family":"Hikida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikatsu","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"30303_CR1","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.3390\/jcm12226956","volume":"12","author":"C Lavalle","year":"2023","unstructured":"Lavalle, C. et al. New challenges in heart failure reduced ejection fraction: managing worsening events. J. Clin. Med. 12, 6956. https:\/\/doi.org\/10.3390\/jcm12226956 (2023).","journal-title":"J. Clin. Med."},{"key":"30303_CR2","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy, S. P., Kakkar, R., McCarthy, C. P. & Januzzi, J. L. Jr. Inflammation in heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 75, 1324\u20131340. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.014 (2020).","journal-title":"J Am Coll Cardiol."},{"key":"30303_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","volume":"73","author":"J Boulet","year":"2024","unstructured":"Boulet, J., Sridhar, V. S., Bouabdallaoui, N., Tardif, J. C. & White, M. Inflammation in heart failure: pathophysiology and therapeutic strategies. Inflamm. Res. 73, 709\u2013723. https:\/\/doi.org\/10.1007\/s00011-023-01845-6 (2024).","journal-title":"Inflamm. Res."},{"key":"30303_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3390\/jcm9051366","volume":"9","author":"R Guieu","year":"2020","unstructured":"Guieu, R. et al. Adenosine and the cardiovascular system: the good and the bad. J. Clin. Med. 9, 1366. https:\/\/doi.org\/10.3390\/jcm9051366 (2020).","journal-title":"J. Clin. Med."},{"key":"30303_CR5","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/molecules28052102","volume":"28","author":"S Sudi","year":"2023","unstructured":"Sudi, S., Thomas, F. M., Daud, S. K., Ag Daud, D. M. & Sunggip, C. The pleiotropic role of extracellular atp in myocardial remodelling. Molecules. 28, 2102. https:\/\/doi.org\/10.3390\/molecules28052102 (2023).","journal-title":"Molecules."},{"key":"30303_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.122.060860","volume":"147","author":"Y Higashikuni","year":"2023","unstructured":"Higashikuni, Y. et al. NLRP3 inflammasome activation through heart-brain interaction initiates cardiac inflammation and hypertrophy during pressure overload. Circulation. 147, 338\u2013355. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060860 (2023).","journal-title":"Circulation."},{"key":"30303_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3892\/mmr.2023.12961","volume":"27","author":"AF Bin Dayel","year":"2023","unstructured":"Bin Dayel, A. F., Alonazi, A. S., Alshammari, T. K. & Alrasheed, N. M. P2X7 purinergic receptor: a potential target in heart diseases. Mol. Med. Rep. 27, 74. https:\/\/doi.org\/10.3892\/mmr.2023.12961 (2023).","journal-title":"Mol. Med. Rep."},{"key":"30303_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183408","volume":"1862","author":"N Hasuzawa","year":"2020","unstructured":"Hasuzawa, N., Moriyama, S., Moriyama, Y. & Nomura, M. Physiopathological roles of vesicular nucleotide transporter (VNUT), an essential component for vesicular ATP release. Biochim. Biophys. Acta Biomembr. 1862, 183408. https:\/\/doi.org\/10.1016\/j.bbamem.2020.183408 (2020).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"30303_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.tips.2017.10.007","volume":"39","author":"Y Moriyama","year":"2018","unstructured":"Moriyama, Y. & Nomura, M. Clodronate: a vesicular ATP release blocker. Trends Pharmacol Sci. 39, 13\u201323. https:\/\/doi.org\/10.1016\/j.tips.2017.10.007 (2018).","journal-title":"Trends Pharmacol Sci."},{"key":"30303_CR10","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1038\/s41598-024-58043-5","volume":"14","author":"T Tokumaru","year":"2024","unstructured":"Tokumaru, T. et al. Hepatic extracellular ATP\/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease. Sci. Rep. 14, 7813. https:\/\/doi.org\/10.1038\/s41598-024-58043-5 (2024).","journal-title":"Sci. Rep."},{"key":"30303_CR11","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1038\/s41598-021-83144-w","volume":"11","author":"N Hasuzawa","year":"2021","unstructured":"Hasuzawa, N. et al. Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury. Sci. Rep. 11, 5192. https:\/\/doi.org\/10.1038\/s41598-021-83144-w (2021).","journal-title":"Sci. Rep."},{"key":"30303_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2018.06.042","volume":"174","author":"F Sun","year":"2018","unstructured":"Sun, F. et al. A genetically encoded fluorescent sensor enables rapid and specific detection of dopamine in flies, fish, and mice. Cell. 174, 481\u2013496. https:\/\/doi.org\/10.1016\/j.cell.2018.06.042 (2018).","journal-title":"Cell."},{"key":"30303_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/01.CIR.94.4.817","volume":"94","author":"ML Roy","year":"1996","unstructured":"Roy, M. L., Dumaine, R. & Brown, A. M. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation. 94, 817\u2013823. https:\/\/doi.org\/10.1161\/01.CIR.94.4.817 (1996).","journal-title":"Circulation."},{"key":"30303_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4070\/kcj.2022.0210","volume":"53","author":"I Kim","year":"2023","unstructured":"Kim, I., Seok, S. H. & Lee, H. Y. Development of a zebrafish larvae model for diabetic heart failure with reduced ejection fraction. Korean Circ J. 53, 34\u201346. https:\/\/doi.org\/10.4070\/kcj.2022.0210 (2023).","journal-title":"Korean Circ J."},{"key":"30303_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112695","volume":"148","author":"M Maciag","year":"2022","unstructured":"Maciag, M., Wnorowski, A., Mierzejewska, M. & Plazinska, A. Pharmacological assessment of zebrafish-based cardiotoxicity models. Biomed. Pharmacother. 148, 112695. https:\/\/doi.org\/10.1016\/j.biopha.2022.112695 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"30303_CR16","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4070\/kcj.2017.0080","volume":"47","author":"G Gu","year":"2017","unstructured":"Gu, G., Na, Y., Chung, H., Seok, S. H. & Lee, H. Y. Zebrafish larvae model of dilated cardiomyopathy induced by terfenadine. Korean Circ. J. 47, 960\u2013969. https:\/\/doi.org\/10.4070\/kcj.2017.0080 (2017).","journal-title":"Korean Circ. J."},{"key":"30303_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.752105","volume":"13","author":"SA Santos","year":"2022","unstructured":"Santos, S. A. et al. P2X7 receptor triggers lysosomal leakage through calcium mobilization in a mechanism dependent on pannexin-1 hemichannels. Front. Immunol. 13, 752105. https:\/\/doi.org\/10.3389\/fimmu.2022.752105 (2022).","journal-title":"Front. Immunol."},{"key":"30303_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12529","author":"T Masuda","year":"2016","unstructured":"Masuda, T. et al. Dorsal horn neurons release extracellular ATP in a VNUT-dependent manner that underlies neuropathic pain. Nat. Commun. https:\/\/doi.org\/10.1038\/ncomms12529 (2016).","journal-title":"Nat. Commun."},{"key":"30303_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s12264-021-00641-8","volume":"37","author":"W Cheng","year":"2021","unstructured":"Cheng, W. et al. Paraventricular nucleus P2X7 receptors aggravate acute myocardial infarction injury via ROS-induced vasopressin-V1b activation in rats. Neurosci. Bull. 37, 641\u201356. https:\/\/doi.org\/10.1007\/s12264-021-00641-8 (2021).","journal-title":"Neurosci. Bull."},{"key":"30303_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007148","volume":"7","author":"N Robbins","year":"2018","unstructured":"Robbins, N. et al. Probenecid improves cardiac function in patients with heart failure with reduced ejection fraction in vivo and cardiomyocyte calcium sensitivity in vitro. J. Am. Heart Assoc. 7, e007148. https:\/\/doi.org\/10.1161\/JAHA.117.007148 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"30303_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/bph.16001","volume":"180","author":"Z On\u00f3di","year":"2023","unstructured":"On\u00f3di, Z., Koch, S., Rubinstein, J., Ferdinandy, P. & Varga, Z. V. Drug repurposing for cardiovascular diseases: New targets and indications for probenecid. Br. J. of Pharmacol. 180, 685\u2013700. https:\/\/doi.org\/10.1111\/bph.16001 (2023).","journal-title":"Br. J. of Pharmacol."},{"key":"30303_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.15420\/aer.2019.05","volume":"8","author":"GD Matthews","year":"2019","unstructured":"Matthews, G. D. & Grace, A. A. Unmasking adenosine: the purinergic signalling molecule critical to arrhythmia pathophysiology and management. Arrhythm Electrophysiol. Rev. 8, 240 (2019).","journal-title":"Arrhythm Electrophysiol. Rev."},{"key":"30303_CR23","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3389\/fphys.2018.01750","volume":"9","author":"M Cerrone","year":"2018","unstructured":"Cerrone, M. et al. Blockade of the adenosine 2A receptor mitigates the cardiomyopathy induced by loss of plakophilin-2 expression. Front. Physiol. 9, 1750. https:\/\/doi.org\/10.3389\/fphys.2018.01750 (2018).","journal-title":"Front. Physiol."},{"key":"30303_CR24","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1161\/CIRCRESAHA.116.304678","volume":"116","author":"S Wagner","year":"2015","unstructured":"Wagner, S., Maier, L. S. & Bers, D. M. Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death. Circ. res. 116, 1956\u20131970. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304678 (2015).","journal-title":"Circ. res."},{"key":"30303_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pbiomolbio.2020.02.008","volume":"157","author":"H Sutanto","year":"2020","unstructured":"Sutanto, H. et al. Cardiomyocyte calcium handling in health and disease: Insights from in vitro and in silico studies. Prog. Biophys. Mol. Biol. 157, 54\u201375. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2020.02.008 (2020).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"30303_CR26","first-page":"58","volume":"57","author":"CK Wallace","year":"2018","unstructured":"Wallace, C. K. et al. Effectiveness of rapid cooling as a method of euthanasia for young zebrafish (Danio rerio). J. Am. Assoc. Lab. Anim. 57, 58\u201363 (2018).","journal-title":"J. Am. Assoc. Lab. Anim."},{"key":"30303_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/978-1-4939-7883-0_27","volume":"1797","author":"HC Yalcin","year":"2018","unstructured":"Yalcin, H. C. Hemodynamic studies for analyzing the teratogenic effects of drugs in the zebrafish embryo. Teratog. Test. Methods Protoc. 1797, 487\u2013495. https:\/\/doi.org\/10.1007\/978-1-4939-7883-0_27 (2018).","journal-title":"Teratog. Test. Methods Protoc."},{"key":"30303_CR28","doi-asserted-by":"publisher","DOI":"10.3791\/60976","volume":"157","author":"A Evangelisti","year":"2020","unstructured":"Evangelisti, A. et al. High-frequency ultrasound echocardiography to assess zebrafish cardiac function. JoVE. 157, e60976. https:\/\/doi.org\/10.3791\/60976 (2020).","journal-title":"JoVE."},{"key":"30303_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/info14060341","volume":"14","author":"MH Huang","year":"2023","unstructured":"Huang, M. H., Naderi, A. M., Zhu, P., Xu, X. & Cao, H. Assessing cardiac functions of zebrafish from echocardiography using deep learning. Information. 14, 341. https:\/\/doi.org\/10.3390\/info14060341 (2023).","journal-title":"Information."},{"key":"30303_CR30","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/cvr\/cvae139","volume":"120","author":"O Weeks","year":"2024","unstructured":"Weeks, O. et al. Embryonic alcohol exposure in zebrafish predisposes adults to cardiomyopathy and diastolic dysfunction. Cardiovasc. Res. 120, 1607\u20131621. https:\/\/doi.org\/10.1093\/cvr\/cvae139 (2024).","journal-title":"Cardiovasc. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30303-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30303-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30303-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:06:00Z","timestamp":1781633160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30303-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30303"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30303-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8220"}}